Breaking News, Collaborations & Alliances

Applied DNA & ACG Sign Agreement

ACG will use Applied DNA's SigNature molecular tagging & authentication technologies to develop empty hard-shell capsules

Applied DNA Sciences and ACG have signed a memorandum of understanding (MoU) that will allow ACG to utilize Applied DNA’s SigNature® molecular tagging and authentication technologies to develop molecularly tagged empty hard-shell capsules.     The development of molecularly tagged empty hard-shell capsules will allow ACG’s customers to enhance every distribution channel’s integrity. It will also provide pharmaceutical companies with increased and assured capabilities wh...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters